Cargando…

A [68Ga]Ga-DOTANOC PET/CT Radiomic Model for Non-Invasive Prediction of Tumour Grade in Pancreatic Neuroendocrine Tumours

Predicting grade 1 (G1) and 2 (G2) primary pancreatic neuroendocrine tumour (panNET) is crucial to foresee panNET clinical behaviour. Fifty-one patients with G1-G2 primary panNET demonstrated by pre-surgical [68Ga]Ga-DOTANOC PET/CT and diagnostic conventional imaging were grouped according to the tu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bevilacqua, Alessandro, Calabrò, Diletta, Malavasi, Silvia, Ricci, Claudio, Casadei, Riccardo, Campana, Davide, Baiocco, Serena, Fanti, Stefano, Ambrosini, Valentina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150289/ https://www.ncbi.nlm.nih.gov/pubmed/34065981 http://dx.doi.org/10.3390/diagnostics11050870

Ejemplares similares

[68Ga]Ga-DOTANOC Uptake at Pancreatic Head/Uncinate Process: Is It a Persistent Diagnostic Pitfall Over Time?
por: Tabacchi, Elena, et al.
Publicado: (2022)

Whole-Body 68Ga-DOTANOC PET/MRI Versus 68Ga-DOTANOC PET/CT in Patients With Neuroendocrine Tumors: A Prospective Study in 28 Patients
por: Berzaczy, Dominik, et al.
Publicado: (2017)

Imaging Acute Myocarditis with 68Ga-DOTANOC PET/CT
por: Jaleel, Jasim, et al.
Publicado: (2023)

Comparison of (68)Ga-DOTANOC PET/CT and contrast-enhanced CT in localisation of tumours in ectopic ACTH syndrome
por: Goroshi, Majunath R, et al.
Publicado: (2016)

Paget’s Disease Mimicking Bone Metastasis in a Patient with Neuroendocrine Tumor on (68)Ga-DOTANOC PET/CT
por: Gezer, Naciye Sinem, et al.
Publicado: (2016)

Neuroendocrine Differentiation of Prostate Cancer Metastases Evidenced “in Vivo” by (68)Ga-DOTANOC PET/CT: Two Cases
por: Savelli, Giordano, et al.
Publicado: (2014)

A Case of Pancreatic Neuroendocrine Tumor With Extensive Skeletal Metastases Detected on 68Ga-DOTANOC PET-CT
por: Wakankar, Ritwik
Publicado: (2023)

Meningiomas: A Comparative Study of (68)Ga-DOTATOC, (68)Ga-DOTANOC and (68)Ga-DOTATATE for Molecular Imaging in Mice
por: Soto-Montenegro, María Luisa, et al.
Publicado: (2014)

Juvenile Nasal Angiofibroma on (68)Ga-DOTANOC PET/CT: Exploring Theranostic Avenues
por: Sakthivel, Pirabu, et al.
Publicado: (2020)

Incidental detection of a tumour on 68-Gallium DOTANOC PET/CT
por: Shah, Hina J., et al.
Publicado: (2014)

Incidental Meningioma on (68)Ga-DOTANOC Positron-Emission Tomography
por: Parihar, Ashwin Singh, et al.
Publicado: (2018)

Multifocal Meningioma Recurrence Detected on Ga68-DOTANOC Scan
por: Gupta, Nitin, et al.
Publicado: (2020)

111In-Octreoscan SPECT/CT hybrid imaging and 68Ga-DOTANOC PET/CT in neuroendocrine adenoma of the middle ear (NAME)
por: Pontico, Mariano, et al.
Publicado: (2020)

Vascular thrombosis as a cause of abdominal pain in a patient with neuroendocrine carcinoma of pancreas: Findings on (68)Ga-DOTANOC PET/CT
por: Naswa, Niraj, et al.
Publicado: (2012)

Von Hippel-Lindau Syndrome: Demonstration of Entire Disease Spectrum with (68)Ga-DOTANOC PET-CT
por: Sharma, Punit, et al.
Publicado: (2014)

Prospective Multicentric Assessment of (68)Ga-DOTANOC PET/CT in Grade 1-2 GEP-NET
por: Lugat, Alexandre, et al.
Publicado: (2023)

Graves' Ophthalmopathy on (68)Ga-DOTANOC Positron Emission Tomography/Computed Tomography
por: Arora, Saurabh, et al.
Publicado: (2019)

Staging of neuroendocrine tumours: comparison of [(68)Ga]DOTATOC multiphase PET/CT and whole-body MRI
por: Schraml, C., et al.
Publicado: (2013)

Comparison of 68Ga-DOTANOC with 18F-FDG using PET/MRI imaging in patients with pulmonary tuberculosis
por: Naftalin, Claire M., et al.
Publicado: (2020)

Quantitative analysis of phantom studies of (111)In and (68)Ga imaging of neuroendocrine tumours
por: Jönsson, L., et al.
Publicado: (2018)

Correlation of Somatostatin Receptor 1–5 Expression, [(68)Ga]Ga-DOTANOC, [(18)F]F-FDG PET/CT and Clinical Outcome in a Prospective Cohort of Pancreatic Neuroendocrine Neoplasms
por: Majala, Susanna, et al.
Publicado: (2021)

Tumour-to-liver ratio determined by [(68)Ga]Ga-DOTA-TOC PET/CT as a prognostic factor of lanreotide efficacy for patients with well-differentiated gastroenteropancreatic-neuroendocrine tumours
por: Kim, Yong-il, et al.
Publicado: (2020)

Positive (68)Ga-DOTANOC PET/CT with negative (131)I- metaiodobenzylguanidine scan in a case of Glomus Jugulare
por: Damle, Nishikant A., et al.
Publicado: (2013)

Unusual Presentation of Bladder Paraganglioma: Comparison of (131)I MIBG SPECT/CT and (68)Ga DOTANOC PET/CT
por: Jain, Tarun Kumar, et al.
Publicado: (2016)

Ectopic Parathyroid Adenoma Mimicking as a Neuroendocrine Tumor on Ga68- DOTANOC Positron Emission Tomography/Computed Tomography Imaging
por: Subramanian, Karthikeyan, et al.
Publicado: (2021)

Comparison of 68Ga-DOTANOC and 18F-FDG PET-CT Scans in the Evaluation of Primary Tumors and Lymph Node Metastasis in Patients With Rectal Neuroendocrine Tumors
por: Zhou, Zhihao, et al.
Publicado: (2021)

Comparison of diagnostic efficacy of (18)F-FDG PET/CT and (68)Ga-DOTANOC PET/CT in ectopic adrenocorticotropic hormone syndrome
por: Zhang, Bing, et al.
Publicado: (2022)

Correction to: Quantitative analysis of phantom studies of (111)In and (68)Ga imaging of neuroendocrine tumours
por: Jönsson, L., et al.
Publicado: (2022)

Al[(18)F]F-NOTA-Octreotide Is Comparable to [(68)Ga]Ga-DOTA-TATE for PET/CT Imaging of Neuroendocrine Tumours in the Latin-American Population
por: Haeger, Arlette, et al.
Publicado: (2023)

A dual tracer (68)Ga-DOTANOC PET/CT and (18)F-FDG PET/CT pilot study for detection of cardiac sarcoidosis
por: Gormsen, Lars C., et al.
Publicado: (2016)

The role of [(68) Ga]Ga-DOTATATE PET/CT in wild-type KIT/PDGFRA gastrointestinal stromal tumours (GIST)
por: Aloj, Luigi, et al.
Publicado: (2021)

Current Status of (68)Ga-Pentixafor in Solid Tumours
por: Hadebe, Bawinile, et al.
Publicado: (2022)

Impact of segmentation and discretization on radiomic features in (68)Ga-DOTA-TOC PET/CT images of neuroendocrine tumor
por: Liberini, Virginia, et al.
Publicado: (2021)

Effect of Peptide Receptor Radionuclide Therapy on Somatostatin Receptor Status and Glucose Metabolism in Neuroendocrine Tumors: Intraindividual Comparison of Ga-68 DOTANOC PET/CT and F-18 FDG PET/CT
por: Oh, Sowon, et al.
Publicado: (2011)

Diagnosis of Men-I Syndrome on (68)Ga-DOTANOC PET-CT and Role of Peptide Receptor Radionuclide Therapy With (177)Lu-DOTATATE
por: kumar Gupta, Santosh, et al.
Publicado: (2012)

18F-DOPA PET/CT and 68Ga-DOTANOC PET/CT scans as diagnostic tools in focal congenital hyperinsulinism: a blinded evaluation
por: Christiansen, Charlotte Dahl, et al.
Publicado: (2017)

[(68)Ga]Ga-DOTA-TOC: The First FDA-Approved (68)Ga-Radiopharmaceutical for PET Imaging
por: Hennrich, Ute, et al.
Publicado: (2020)

Coexisting Somatostatin Receptor Expressing Gastric Neuroendocrine Tumor Primary and Lymph Nodal Tuberculosis on (68)Ga-DOTANOC Positron Emission Tomography/Computed Tomography
por: Arora, Saurabh, et al.
Publicado: (2020)

Recurrent malignant pheochromocytoma with unusual omental metastasis: (68)Ga-DOTANOC PET/CT and (131)I-MIBG SPECT/CT scintigraphy findings
por: Arora, Saurabh, et al.
Publicado: (2014)

Radiomics in pulmonary neuroendocrine tumours (NETs)
por: Cozzi, Diletta, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_suegbie4hlov9tq74on8uk2hiu